Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-25 @ 2:02 PM
NCT ID:
NCT02595892
Group ID:
EG001
Title:
Arm II (Gemcitabine, ATR Kinase Inhibitor M6620)
Description:
Patients receive gemcitabine hydrochloride as in Arm I and ATR kinase inhibitor M6620 IV over 60-90 minutes on days 2 and 9. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Berzosertib: Given IV
Gemcitabine: Given IV
Gemcitabine Hydrochloride: Given IV
Deaths Number Affected:
24
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
34
Other Number Affected:
34
Other Number At Risk:
34
Study:
NCT02595892
Results Section:
NCT02595892
Adverse Events Module:
NCT02595892